Terms: = Germ cell tumor AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK AND Staging
98 results:
1. The Clinical Utility of Gallium-68-DOTATATE Positron Emission Tomography Scanning in Medullary Thyroid Cancer.
Gild ML; Kumar S; Fuchs TL; Glover A; Sidhu S; Sywak M; Tsang V; Gill AJ; Robinson BG; Schembri G; Clifton-Bligh RJ; Hoang J
Endocr Pract; 2024 Mar; 30(3):218-224. PubMed ID: 38103829
[TBL] [Abstract] [Full Text] [Related]
2. Preoperative neck ultrasound combined with pathological data can significantly impact the outcome of medullary thyroid carcinoma.
Deandrea M; Piticchio T; Mormile A; Retta F; Canale G; Caracciolo A; Daniele L; Trimboli P
Endocr J; 2023 Nov; 70(11):1061-1067. PubMed ID: 37690841
[TBL] [Abstract] [Full Text] [Related]
3. Medullary thyroid carcinoma.
Pelizzo MR; Mazza EI; Mian C; Merante Boschin I
Expert Rev Anticancer Ther; 2023; 23(9):943-957. PubMed ID: 37646181
[TBL] [Abstract] [Full Text] [Related]
4. A Proposed Modified staging System for Medullary Thyroid Cancer: A SEER Analysis With Multicenter Validation.
Wang Z; Fan X; Zha X; Xu Y; Yin Z; Rixiati Y; Yu F
Oncologist; 2024 Jan; 29(1):e59-e67. PubMed ID: 37311049
[TBL] [Abstract] [Full Text] [Related]
5. Clinical Evolution of Sporadic Medullary Thyroid Carcinoma With Biochemical Incomplete Response After Initial Treatment.
Prete A; Gambale C; Torregrossa L; Ciampi R; Romei C; Ramone T; Agate L; Bottici V; Cappagli V; Molinaro E; Materazzi G; Elisei R; Matrone A
J Clin Endocrinol Metab; 2023 Jul; 108(8):e613-e622. PubMed ID: 36722192
[TBL] [Abstract] [Full Text] [Related]
6. Update on Management of Medullary Thyroid Carcinoma: Focus on Nuclear Medicine.
Treglia G; Rufini V; Piccardo A; Imperiale A
Semin Nucl Med; 2023 Jul; 53(4):481-489. PubMed ID: 36702731
[TBL] [Abstract] [Full Text] [Related]
7. Thyroidectomy Outcomes in Patients Identified With RET Pathogenic Variants Through a Population Genomic Screening Program.
Pichardo PFA; Hellums RN; Hao J; Savatt JM; Hassen D; Pellitteri PK; Alvi M; Buchanan AH; Purdy NC
JAMA Otolaryngol Head Neck Surg; 2023 Mar; 149(3):195-202. PubMed ID: 36602781
[TBL] [Abstract] [Full Text] [Related]
8. Inclusion of the Number of Metastatic Lymph Nodes in the staging System for Medullary Thyroid Cancer: Validating a Modified American Joint Committee on Cancer tumor-Node-Metastasis staging System.
Wang Z; Tang C; Wang Y; Yin Z; Rixiati Y
Thyroid; 2022 May; 32(5):536-543. PubMed ID: 35350868
[No Abstract] [Full Text] [Related]
9. Distant metastasis in medullary thyroid carcinoma: Clinical outcomes and implications of T stage.
Shao Y; Li G; Wei T; Gong R; Li Z; Zhu J; Lei J
Clin Endocrinol (Oxf); 2022 Nov; 97(5):676-684. PubMed ID: 35261045
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of F-18 DOPA PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET/CT.
Asa S; Sonmezoglu K; Uslu-Besli L; Sahin OE; Karayel E; Pehlivanoglu H; Sager S; Kabasakal L; Ocak M; Sayman HB
Ann Nucl Med; 2021 Aug; 35(8):900-915. PubMed ID: 33993425
[TBL] [Abstract] [Full Text] [Related]
11. Ultrasound features of medullary thyroid cancer as predictors of biological behavior.
Zhao J; Zheng X; Gao M; Zhang S; Yun X; Chi J; Xu G
Cancer Imaging; 2021 Apr; 21(1):33. PubMed ID: 33836831
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic value of [
Jamsek J; Hocevar M; Bergant D; Zaletel K; Rep S; Lezaic L
Ann Nucl Med; 2021 Apr; 35(4):429-437. PubMed ID: 33544320
[TBL] [Abstract] [Full Text] [Related]
13. Construction and Validation of a Nomogram Based on the Log Odds of Positive Lymph Nodes to Predict the Prognosis of Medullary Thyroid Carcinoma After Surgery.
Tang J; Jiang S; Gao L; Xi X; Zhao R; Lai X; Zhang B; Jiang Y
Ann Surg Oncol; 2021 Aug; 28(8):4360-4370. PubMed ID: 33469797
[TBL] [Abstract] [Full Text] [Related]
14. An Overview of Medullary Thyroid Cancer Cases Treated at Kuwait Cancer Control Center.
Shete J; AlSaleh K; Safwat R; Bedair A; ElSherify M; Hussein A; Nazeeh M; Mohanty A
Gulf J Oncolog; 2020 Sep; 1(34):39-47. PubMed ID: 33431361
[TBL] [Abstract] [Full Text] [Related]
15. Nodal disease burden and outcome of medullary thyroid carcinoma.
Moses LE; Oliver JR; Rotsides JM; Shao Q; Patel KN; Morris LGT; Givi B
Head Neck; 2021 Feb; 43(2):577-584. PubMed ID: 33107153
[TBL] [Abstract] [Full Text] [Related]
16. Role of tissue and circulating microRNAs and DNA as biomarkers in medullary thyroid cancer.
Chiacchiarini M; Trocchianesi S; Besharat ZM; Po A; Ferretti E
Pharmacol Ther; 2021 Mar; 219():107708. PubMed ID: 33091426
[TBL] [Abstract] [Full Text] [Related]
17. Identification of prognostic long noncoding RNAs associated with spontaneous regression of neuroblastoma.
Meng X; Fang E; Zhao X; Feng J
Cancer Med; 2020 Jun; 9(11):3800-3815. PubMed ID: 32216054
[TBL] [Abstract] [Full Text] [Related]
18. The added diagnostic value of complementary gadoxetic acid-enhanced MRI to
Puhr-Westerheide D; Cyran CC; Sargsyan-Bergmann J; Todica A; Gildehaus FJ; Kunz WG; Stahl R; Spitzweg C; Ricke J; Kazmierczak PM
Cancer Imaging; 2019 Nov; 19(1):73. PubMed ID: 31727170
[TBL] [Abstract] [Full Text] [Related]
19. Protean cytological, histological and immunohistochemical appearances of medullary thyroid carcinoma: current updates.
Buzdugă CM; Costea CF; Cărăuleanu A; Lozneanu L; Turliuc MD; Cucu AI; Ciocoiu M; Floria M; Tănase DM; Dragomir RA; Haba RM; Dumitrescu AM; Bogdănici CM; Ciobanu Apostol DG
Rom J Morphol Embryol; 2019; 60(2):369-381. PubMed ID: 31658309
[TBL] [Abstract] [Full Text] [Related]
20. A Novel N staging System for Predicting Survival in Patients with Medullary Thyroid Cancer.
Chen L; Qian K; Guo K; Zheng X; Sun W; Sun T; Wang Y; Li D; Wu Y; Ji Q; Wang Z
Ann Surg Oncol; 2019 Dec; 26(13):4430-4438. PubMed ID: 31552613
[TBL] [Abstract] [Full Text] [Related]
[Next]